Lobbying Filing Details

Total Spending

$3,340,000

Activities

8

Lobbyists

14

Gov't Entities

17

Filing Information
Filing UUID:
d8fec76a-bd38-47e2-80aa-d70b02e45ee7
Type:
Q1 - 1st Quarter - Report
Period:
2025 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 21, 2025 at 5:20 PM
Income:
$0
Expenses:
$3,340,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Jane Adams
Registrant
JOHNSON & JOHNSON SERVICES, INC.
NEW BRUNSWICK, New Jersey
Client
JOHNSON & JOHNSON SERVICES INC
New Jersey, United States of America
Lobbying Activities (8)
Activity 1
Budget/Appropriations

- Issues related to stroke care

Lobbyists (1)
  • LEIF BRIERLEY
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Copyright/Patent/Trademark

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions Issues related to - intellectual property, including S. 1040, a bill to amend the Federal Trade Commission Act to prohibit product hopping - Medication Affordability and Patent Integrity Act - patent thickets

Lobbyists (4)
  • DAVID KAVANAUGH
  • RILEY SWINEHART
  • WENDY SUSSMAN
  • TIMOTHY SWOPE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. XXXX/ S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, H.R. XXX HELP Copays Act, regarding all provisions - H.R. 2214/ S. XXXX Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day

Lobbyists (14)
  • MRS. JANE MARGARET ADAMS
  • DAVID KAVANAUGH
  • KELLY WATERS
  • LEIF BRIERLEY
  • LARRY CAMM
  • RILEY SWINEHART
  • ABIGAIL PINKELE
  • DEANA MCRAE
  • AMY PELLEGRINO
  • WENDY SUSSMAN
  • MRS. MEGHAN DRENAN STONE
  • TIMOTHY SWOPE
  • COLLEEN VIVALDI
  • DANIELLE MITCHELL
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 4
Law Enforcement/Crime/Criminal Justice

Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - the Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding

Lobbyists (3)
  • MRS. JANE MARGARET ADAMS
  • KELLY WATERS
  • RILEY SWINEHART
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 5
Pharmacy

- Issues related to the SUPPORT Act

Lobbyists (1)
  • AMY PELLEGRINO
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 6
Science/Technology

Issues related to - artificial intelligence - data privacy - cybersecurity - robotics

Lobbyists (1)
  • LEIF BRIERLEY
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 7
Taxation/Internal Revenue Code

Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in TCJA including in 2025 reconciliation bills

Lobbyists (3)
  • DAVID KAVANAUGH
  • KELLY WATERS
  • RILEY SWINEHART
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Treasury, Dept of
Activity 8
Veterans

- Issues related to Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology

Lobbyists (1)
  • RILEY SWINEHART
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 5, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.